NY Times

Advertismentspot_img

The jury deliberates for a second day in the trial of Elizabeth Holmes.

Closing arguments in the case concluded last week. On Monday, jurors began deliberating at around 8:30 a.m. They left the courthouse around 4 p.m.  » mehr lesen

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles

A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment.  » mehr lesen

U.S. and Britain Help Ukraine Prepare for Potential Russian Cyberassault

Russia has attacked Ukraine’s power grid in the past, and experts say Moscow might take similar steps as it masses troops along the border.  » mehr lesen

Oracle to Buy Cerner for $28.3 Billion

Cerner is No. 2 in the electronic health record business with 25 percent of the market.  » mehr lesen

Rothy’s, the recycled-plastic footwear brand, gets a deal valuing it at $1 billion.

The Brazilian owner of Havaianas, the maker of flip flops, is taking a 49.9 percent stake in the San Francisco company.  » mehr lesen

How Truck Drivers Cook on the Road

Long-haul drivers are under intense pressure this season, but many will carve out the time (and the onboard space) to make steaks, turkeys and charcuterie boards.  » mehr lesen

Davos Is Postponed Over Omicron’s Spread

The World Economic Forum postponed its annual gathering of business and government leaders over fears of the Omicron variant.  » mehr lesen

A $550 Million Springsteen Deal? It’s Glory Days for Catalog Sales.

Bob Dylan, Paul Simon, Tina Turner and others have all sold rights to their music for eye-popping prices. Here’s why.  » mehr lesen

NY Times

Advertismentspot_img